期刊文献+

抗乳腺癌单抗CDI315B可变区基因的序列分析 被引量:1

SEQUENCE OF V ARIABLE VREGION GENES FOR ANTI BREAST CANCER McAb CDI 315B
下载PDF
导出
摘要 目的 :克隆抗乳腺癌 CDI315 B单抗可变区基因 ,并对其进行序列分析。方法 :利用前导肽序列设计引物 ,采用 RT-PCR技术从分泌抗人乳腺癌单克隆抗体的杂交瘤细胞株 CDI315 B分离克隆了抗体轻重链可变区基因 ,用 Sanger双脱氧末端终止法测定扩增的 CDI315 B单抗 VK 和 VH 基因的序列 ,对其进行序列分析。结果 :和国际标准的小鼠 Kabat分类体系进行对比分析 ,CDI315 B单抗的 VK属于第 4或第 5组的第 6亚组 (VI) ;CDI315 B单抗的 VH 则属于第 2族 (VH2 )。结论 :抗乳腺癌 CDI315 B单抗可变区基因的克隆及序列分析为构建人鼠嵌合轻链和人鼠嵌合重链打下基础。 Objective:To clone and sequence the V region genes of anti breast cancer McAb CDI 315B Methods:The entire V H and V K genes of anti breast cancer McAb CDI 315B were amplified by RT PCR method from CDI 315B hybridoma cell,using 5′primer and 3′primer as leader sequences for the light chain gene and heavy chain gene,respectively Their nucleotide sequences were determined using Sanger′s method Results:The cDNA sequences of V H and V K region genes were compared to the murine sequences from Kabat database,in which the CDI 315B V K region belongs to the 4/5 group V K subgroup VI and the CDI 315 V H region belongs to V H2 family Conclusion:This result will lay a foundation for the construction of CDI 315B human mouse chimeric light chain and heavy chain
出处 《广西医科大学学报》 CAS 2000年第1期53-55,共3页 Journal of Guangxi Medical University
关键词 抗乳腺癌单克隆抗体 可变区基因 乳腺癌 anti breast cancer McAb V region genes sequence
  • 相关文献

参考文献3

  • 1Neuberger MS,Williams GT,Mitchell EB,etal.A hapten- specific chimeric Ig E antibody with hum an physiologicaleffector function[].Nature.1985
  • 2Morrison SL,Johnson MJ,Herzenberg L A,etal.Chimerichum an antibody molecular:mouse antigen- bindingdom ains with human constant region dom ains[].Proceedings of the National Academy of Sciences of the United States of America.1984
  • 3Kohler G,Milstein C.Continuous culture of fused cells secreting antibody of pre- defined specificity[].Nature.1975

同被引文献7

  • 1Kohler G ,Milstein C. Continuous culture of fused cells secreting antibody of pre-defined specificity. Nature, 1975,256:495-497.
  • 2Levy R,Miller R. Biological and clinical implication of lymphocytes hybridomas: tumor therapy with monoclo-nal antibodies. Annu Rev Med, 1983,34:107-116.
  • 3Morrison SL, Johnson MJ, Herzenberg LA, et al. Chimeric human antibody molecular: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA, 1984,81:6 851-6 965.
  • 4Neuberger MS, Williams GT, Mitchell EB, et al. A hapten-specific chimeric IgE antibody with human physiological effector function. Nature, 1985,314:268-270.
  • 5Beketic Oreskovic L, Sarcevic B, Malenica B, et al. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315 raised against human breast carcinoma. Neoplasma, 1993,40:69-74.
  • 6Kabat EA, Wu TT, Perry HM, et al. Sequence of proteins of immunological interest. 5th edition . USA Department of Health and Human Service, Bethesda, 1991.10-20.
  • 7Tao MH,Morrison SL. Study of a glycosylated chimeric mouse-human IgG role of carbohydrate in the structure and effector functons mediated by the human IgG constant region. J Immunol, 1989,143,2 595-2 601.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部